Sign Up Today and Learn More About Nectero Medical Stock
Invest in or calculate the value of your shares in Nectero Medical or other pre-IPO companies through EquityZen's platform.

Nectero Medical Stock (NECM)
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.
About Nectero Medical Stock
Founded
2017
Headquarters
Dover, DE, US
Industries
Science and Engineering, Health Care, Biotechnology
Nectero Medical Press Mentions
Stay in the know about the latest news on Nectero Medical
Methods for aneurysm treatment
patents • Feb 08, 2025
Venture capital, private equity markets may see uptick in exits in 2025
bizjournals • Jan 02, 2025
Swing States Are Also In The Middle For Startup Funding
news • Oct 30, 2024
Tempe biotech firm Nectero lands $96M VC investment to support clinical trials - Phoenix Business Journal
bizjournals • Jul 05, 2024
Nectero Medical Announces Completion of $96M Series D Financing
businesswire • May 23, 2024
Nectero Medical Management
Leadership team at Nectero Medical
Board Member
Alan Davis
Board Member
Zack Scott

Join now and verify your accreditation status to gain access to:
- Nectero Medical Current Valuation
- Nectero Medical Stock Price
- Nectero Medical Management
- Available deals in Nectero Medical and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Nectero Medical Cap Table and Funding History by Share Class and Liquidity Preferences
- Nectero Medical Revenue and Financials
- Nectero Medical Highlights
- Nectero Medical Business Model
- Nectero Medical Risk Factors
- Nectero Medical Research Report from SACRA Research
Trading Nectero Medical Stock
How to invest in Nectero Medical stock?
Accredited investors can buy pre-IPO stock in companies like Nectero Medical through EquityZen funds. These investments are made available by existing Nectero Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Nectero Medical stock?
Shareholders can sell their Nectero Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."